Profile
Mr. Gaétan Gravel is a Portfolio Manager at Fonds de Solidarité FTQ.
He is on the Board of Directors at Thrasos Therapeutics, Inc. and GLyPharma Therapeutic, Inc.
Mr. Gravel was previously employed as a Director-Customer Services & Development by Business Development Bank of Canada.
He also served on the board at Mirati Therapeutics, Inc.
Mr. Gravel received his undergraduate degree from HEC Montréal.
Gaétan Gravel active positions
| Companies | Position | Start |
|---|---|---|
Fonds de Solidarité FTQ
Fonds de Solidarité FTQ Investment ManagersFinance Fonds Régional de Solidarité FTQ invests in companies located in Canada, primarily in the Island of Montreal. The firm focuses on manufacturing, distribution, technology, real estate and service sectors. It provide equity or debt financing for growth stage capital requirements with an investment size of up to CAD 5 million and also it takes minority and control positions. | Private Equity Investor | 2010-11-19 |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology Develops oncology therapeutic treatment | Director/Board Member | - |
Former positions of Gaétan Gravel
| Companies | Position | End |
|---|---|---|
Business Development Bank of Canada
Business Development Bank of Canada Finance/Rental/LeasingFinance Provides financing for business expansion and entrepreneurship | Corporate Officer/Principal | 1996-12-31 |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Director/Board Member | - |
| MIRATI THERAPEUTICS | Director/Board Member | 2009-04-30 |
Training of Gaétan Gravel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Business Development Bank of Canada
Business Development Bank of Canada Finance/Rental/LeasingFinance Provides financing for business expansion and entrepreneurship | Finance |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Fonds de Solidarité FTQ
Fonds de Solidarité FTQ Investment ManagersFinance Fonds Régional de Solidarité FTQ invests in companies located in Canada, primarily in the Island of Montreal. The firm focuses on manufacturing, distribution, technology, real estate and service sectors. It provide equity or debt financing for growth stage capital requirements with an investment size of up to CAD 5 million and also it takes minority and control positions. | Finance |
HEC Montréal
HEC Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Health Technology |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology Develops oncology therapeutic treatment | Health Technology |
- Stock Market
- Insiders
- Gaétan Gravel
















